NASDAQ
0.30USD
-0.00 (-0.26%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
4.2M
P/E
—
EPS
—
Beta
6.09
52W range
0.271-5.12
Day range
0.30–0.31
Open
0.31
Prev close
0.31
Volume
119K
Avg volume
1.6M
Dividend
0.00
IPO
2020-12-11
https://www.globenewswire.com/news-release/2026/08/14/3345341/0/en/vivos-therapeutics-schedules-release-of-second-quarter-2026-financial-results-and-conference-call.html · 8/14/2026+0.00
https://www.globenewswire.com/news-release/2026/06/30/3319701/0/en/Vivos-Vida-Appliance-Shows-Statistically-Significant-Improvement-in-Insomnia-Severity-in-100-of-Study-Participants.html · 6/30/2026+0.90
https://www.globenewswire.com/news-release/2026/06/05/3307368/0/en/Vivos-Therapeutics-Announces-Binding-Agreement-for-Senior-Debt-to-Equity-Exchange-of-Up-to-4-5-Million-from-Streeterville-Capital-to-Support-Continued-Nasdaq-Listing.html · 6/5/2026+0.40
https://www.globenewswire.com/news-release/2026/04/07/3269171/0/en/Vivos-Therapeutics-Completes-Private-Placement-with-Existing-Private-Equity-Investor-New-Seneca-Partners.html · 4/7/2026
https://www.benzinga.com/trading-ideas/long-ideas/26/02/50324969/top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-this-quarter-2 · 2/3/2026+0.60
https://www.zacks.com/stock/news/2811914/vivos-therapeutics-vvos-upgraded-to-buy-here-s-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2811914 · 1/5/2026+1.00
https://seekingalpha.com/article/4853776-vivos-therapeutics-inc-vvos-discusses-strategic-business-model-pivot-and-transition-in-sleep · 12/16/2025-0.30
https://www.globenewswire.com/news-release/2025/09/17/3151624/0/en/Vivos-Therapeutics-Announces-Landmark-Clinical-Trial-Results-in-Pediatric-Obstructive-Sleep-Apnea-Treatment.html · 9/17/2025+1.00
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
